Cuu Long Pharmaceutical JSC (HOSE:DCL)

Market Cap	3.58T
Revenue (ttm)	1.46T
Net Income (ttm)	35.78B
Shares Out	73.04M
EPS (ttm)	489.47
PE Ratio	100.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	749,178
Average Volume	817,434
Open	49,000
Previous Close	48,000
Day's Range	48,000 - 49,100
52-Week Range	19,000 - 49,100
Beta	0.60
RSI	75.96
Earnings Date	Jan 27, 2026

About HOSE:DCL

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antiallergy, pain reliever and fever reducer, antibiotic, anti-inflammatory, antiviral, cardiovascular, corticosteroid, cough, dermatology, digestive, nervous system, musculoskeletal, and vitamin and mineral medicines, as well as capsules and medical equipment. The company is also involved in retailing drugs, medical devices, and cosmetics, as well as trades in pharmaceuticals and medical equipment. It sells its products to hospitals, phar...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 885
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DCL

Financial Performance

In 2024, HOSE:DCL's revenue was 1.31 trillion, an increase of 14.24% compared to the previous year's 1.14 trillion. Earnings were 53.57 billion, a decrease of -10.29%.